These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18681305

  • 1. [Donor lymphocyte infusion for treatment of relapse of leukemia after HLA-mismatched hematopoietic stem cell transplantation].
    Liu DH, Liu KY, Xu LP, Han W, Chen H, Chen YH, Zhang XH, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):78-82. PubMed ID: 18681305
    [Abstract] [Full Text] [Related]

  • 2. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X, Wu DP, Sun AN, Fu ZZ, Tang XW, Wu XJ, Liu YJ, Qiu HY, Miao M, Han Y, Jin ZM, Zhao Y, Xue SL, Wang Y, Chen SN, He GS, Zhou HX, Chang HR.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [Abstract] [Full Text] [Related]

  • 4. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [Abstract] [Full Text] [Related]

  • 6. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
    Huang XJ, Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Chen YH, Han W, Shi HX.
    Bone Marrow Transplant; 2009 Sep; 44(5):309-16. PubMed ID: 19234512
    [Abstract] [Full Text] [Related]

  • 7. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia].
    Huang X, Wang F, Guo N.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1348-51. PubMed ID: 11930625
    [Abstract] [Full Text] [Related]

  • 8. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q, Dong M, Wang QM, Wen JY, Wu XY.
    Ai Zheng; 2006 Oct 25; 25(10):1261-5. PubMed ID: 17059772
    [Abstract] [Full Text] [Related]

  • 9. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
    Huang XJ, Han W, Xu LP, Chen YH, Liu DH, Lu J, Chen H, Zhang YC, Jiang Q, Liu KY, Lu DP.
    Chin Med J (Engl); 2004 Dec 25; 117(12):1778-85. PubMed ID: 15603704
    [Abstract] [Full Text] [Related]

  • 10. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J, Meng FY, Liu QF, Xu D, Xu B, Liu XL.
    Ai Zheng; 2003 Dec 25; 22(12):1321-4. PubMed ID: 14693060
    [Abstract] [Full Text] [Related]

  • 11. Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation.
    Yegin ZA, Ozkurt ZN, Aki SZ, Sucak GT.
    Transfus Apher Sci; 2010 Jun 25; 42(3):239-45. PubMed ID: 20385512
    [Abstract] [Full Text] [Related]

  • 12. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P, Ringdén O.
    Bone Marrow Transplant; 2003 Jul 25; 32(2):217-23. PubMed ID: 12838288
    [Abstract] [Full Text] [Related]

  • 13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 25; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 14. Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).
    Michallet AS, Nicolini F, Fürst S, Le QH, Dubois V, Hayette S, Bourgeot JP, Tremisi JP, Thomas X, Gebuhrer L, Michallet M.
    Bone Marrow Transplant; 2005 Mar 25; 35(6):601-8. PubMed ID: 15756285
    [Abstract] [Full Text] [Related]

  • 15. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
    Schmid C, Labopin M, Nagler A, Bornhäuser M, Finke J, Fassas A, Volin L, Gürman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V, EBMT Acute Leukemia Working Party.
    J Clin Oncol; 2007 Nov 01; 25(31):4938-45. PubMed ID: 17909197
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
    Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Bregante S, Berisso G, Mordini N, Incagliato M, Fugazza G, Sessarego M, Bacigalupo A.
    Haematologica; 1998 Oct 01; 83(10):896-903. PubMed ID: 9830798
    [Abstract] [Full Text] [Related]

  • 17. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation.
    Ferrá C, Rodríguez-Luaces M, Gallardo D, Encuentra M, Martín-Henao GA, Peris J, Ancín I, Sarrá J, Berlanga JJ, García J, Grañena A.
    Bone Marrow Transplant; 2001 Nov 01; 28(10):963-8. PubMed ID: 11753552
    [Abstract] [Full Text] [Related]

  • 18. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr 01; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
    Or R, Hadar E, Bitan M, Resnick IB, Aker M, Ackerstein A, Samuel S, Tsirigotis P, Gesundheit B, Slavin S, Shapira MY.
    Biol Blood Marrow Transplant; 2006 Dec 01; 12(12):1295-301. PubMed ID: 17162211
    [Abstract] [Full Text] [Related]

  • 20. Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation.
    Siegert W, Beyer J, Kingreen D, Blasczyk R, Baurmann H, Schwella N, Schleicher J, Kirsch A, Huhn D.
    Bone Marrow Transplant; 1998 Sep 01; 22(6):579-83. PubMed ID: 9758347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.